Dario Paggiarino

Dario Paggiarino

Net worth: 718 427 $ as of 30/05/2024

67 year
Health Technology
Consumer Services

Profile

Dario A.
Paggiarino
is a former Executive Director-Clinical Development at Pfizer Inc. from 2001 to 2011.
He also worked as a Clinical Director at Pharmacia Corp.
and as an Executive Director-Clinical Development at Pfizer (St. Louis).
Additionally, he served as Vice President at Alcon Laboratories, Inc. Dr. Paggiarino was the Chief Development Officer & Senior Vice President at Lpath, Inc. from 2013 to 2016.
He also held the position of President at Angelini Pharmaceuticals Romania SRL.
Currently, he is the Chief Medical Officer & Senior Vice President at EyePoint Pharmaceuticals, Inc. starting from 2019.
Dr. Paggiarino obtained his doctorate degree from Sapienza University of Rome.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
22/04/2024 67,080 ( 0.13% ) 718 427 $ 30/05/2024

Former positions of Dario Paggiarino

CompaniesPositionEnd
EYEPOINT PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 03/03/2024
Corporate Officer/Principal 21/07/2016
PFIZER, INC. Corporate Officer/Principal 31/12/2010
Corporate Officer/Principal -
President -
See the detail of Dario Paggiarino's experience

Training of Dario Paggiarino

Sapienza University of Rome Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dario Paggiarino's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
EYEPOINT PHARMACEUTICALS, INC.

Health Technology

PFIZER, INC.

Health Technology

Private companies5

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Dario Paggiarino